Abstract
The biophysical aspects of stereotaxic treatment are summarized, emphasizing the complex interplay between time-dose-fractionation, partial volume effect, physical dose distribution, and set-up uncertainties in influencing treatment outcome. The radiobiological advantage of dose-fractionation for normal tissue sparing is estimated using the linear-quadratic model and viewed in the context of clinical situations and results. Counterbalancing this benefit is the larger geometrical uncertainty associated with multiple fraction treatment, which would require increased treatment volume and an associated decrease in treatment dose. This last consideration requires knowledge of volume-dose relation of radiation-induced normal brain toxicity, the current status of which is also outlined.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
